33287247|t|Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease.
33287247|a|Gaucher Disease (GD), which is the most common lysosomal storage disorder, is caused by bi-allelic mutations in GBA1-a gene that encodes the lysosomal hydrolase beta-glucocerebrosidase (GCase). The neuronopathic forms of GD (nGD) are characterized by severe neurological abnormalities that arise during gestation or early in infancy. Using GD-induced pluripotent stem cell (iPSC)-derived neuronal progenitor cells (NPCs), we have previously reported that neuronal cells have neurodevelopmental defects associated with the downregulation of canonical Wnt signaling. In this study, we report that GD NPCs display elevated levels of Dkk1, which is a secreted Wnt antagonist that prevents receptor activation. Dkk1 upregulation in mutant NPCs resulted in an increased degradation of beta-catenin, and there was a concomitant reduction in lysosomal numbers. Consistent with these results, incubation of the mutant NPCs with recombinant Wnt3a (rWnt3a) was able to outcompete the excess Dkk1, increasing beta-catenin levels and rescuing lysosomal numbers. Furthermore, the incubation of WT NPCs with recombinant Dkk1 (rDkk1) phenocopied the mutant phenotype, recapitulating the decrease in beta-catenin levels and lysosomal depletion seen in nGD NPCs. This study provides evidence that downregulation of the Wnt/beta-catenin pathway in nGD neuronal cells involves the upregulation of Dkk1. As Dkk1 is an extracellular Wnt antagonist, our results suggest that the deleterious effects of Wnt/beta-catenin downregulation in nGD may be ameliorated by the prevention of Dkk1 binding to the Wnt co-receptor LRP6, pointing to Dkk1 as a potential therapeutic target for GBA1-associated neurodegeneration.
33287247	9	13	Dkk1	Gene	22943
33287247	106	135	Neuronopathic Gaucher Disease	Disease	MESH:D005776
33287247	137	152	Gaucher Disease	Disease	MESH:D005776
33287247	154	156	GD	Disease	MESH:D005776
33287247	184	210	lysosomal storage disorder	Disease	MESH:D016464
33287247	249	253	GBA1	Gene	2629
33287247	298	321	beta-glucocerebrosidase	Gene	2629
33287247	358	360	GD	Disease	MESH:D005776
33287247	362	365	nGD	Disease	
33287247	395	421	neurological abnormalities	Disease	MESH:D009461
33287247	477	479	GD	Disease	MESH:D005776
33287247	612	638	neurodevelopmental defects	Disease	MESH:D065886
33287247	732	734	GD	Disease	MESH:D005776
33287247	767	771	Dkk1	Gene	22943
33287247	843	847	Dkk1	Gene	22943
33287247	916	928	beta-catenin	Gene	1499
33287247	1068	1073	Wnt3a	Gene	89780
33287247	1117	1121	Dkk1	Gene	22943
33287247	1134	1146	beta-catenin	Gene	1499
33287247	1242	1246	Dkk1	Gene	22943
33287247	1320	1332	beta-catenin	Gene	1499
33287247	1372	1375	nGD	Disease	
33287247	1442	1454	beta-catenin	Gene	1499
33287247	1466	1469	nGD	Disease	
33287247	1514	1518	Dkk1	Gene	22943
33287247	1523	1527	Dkk1	Gene	22943
33287247	1620	1632	beta-catenin	Gene	1499
33287247	1651	1654	nGD	Disease	
33287247	1695	1699	Dkk1	Gene	22943
33287247	1731	1735	LRP6	Gene	4040
33287247	1749	1753	Dkk1	Gene	22943
33287247	1792	1796	GBA1	Gene	2629
33287247	1808	1825	neurodegeneration	Disease	MESH:D019636
33287247	Positive_Correlation	MESH:D005776	22943
33287247	Association	22943	4040
33287247	Negative_Correlation	1499	22943
33287247	Association	MESH:D005776	2629
33287247	Bind	22943	89780
33287247	Association	MESH:D019636	22943
33287247	Positive_Correlation	1499	89780
33287247	Association	22943	2629
33287247	Association	MESH:D019636	2629

